Neuromod

Description

Neuromod develops and commercializes Lenire, a bimodal neuromodulation medical device for treating tinnitus, supplying clinicians and patients with an FDA-authorized therapeutic device and related clinical support.

Neuromod is located in the Dublin ecosystem.

Related

• CroíValveCroíValve develops the DUO Adapt™ System, a minimally invasive transcatheter heart valve device for treating tricuspid regurgitation in…
• UroMemsUroMems develops smart active implantable medical devices for treating stress urinary incontinence, including the UroActive system for…
• Jazz PharmaceuticalsJazz Pharmaceuticals develops and commercializes medicines for people with rare diseases, focusing on therapies for epilepsies, cancers and…
• Nia HealthNia Health develops indication-specific medical software platforms that deliver personalized digital therapeutics combining clinical…
• CAREPOI®CAREPOI® creates cloud-native AI healthcare intelligence and telemedicine platforms that link patients, clinicians, diagnostics, and…
• VirtonomyVirtonomy develops digital patient twins and medical simulation platforms that let device developers run data-driven virtual patient…
• ATXA TherapeuticsATXA Therapeutics develops selective small-molecule thromboxane receptor (TP) antagonists, including lead candidate NTP42, to treat…
• LEO PharmaLEO Pharma develops and delivers innovative treatments for medical dermatology, producing medicines and supplying healthcare providers and…
• Trained Therapeutix DiscoveryTrained Therapeutix Discovery develops nanobiologic therapeutics that regulate trained immunity for applications in cancer and organ…